Lab
Pmdca, LLC
Pmdca, LLC was paid $6.99M by Medicaid between Mar 2020 and May 2024, across 55 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 72% of everything it billed.
33Billing provider infoPMDCA, LLC
LAGUNA HILLS, CA 92653
LAGUNA HILLS, CA 92653
33aNPI1912383183assigned 08/10/2015
33bProvider typeClinical Medical Laboratory
28Total paid$6.99M
24GClaims166,850
24DCodes billed55
24AFirst – last monthMar 2020 – May 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in California
Rank by total paid#88 of 561
Median peer was paid$222K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,297 | $4K | |
| 2021 | 18,532 | $650K | |
| 2022 | 62,097 | $2.78M | |
| 2023 | 74,738 | $3.05M | |
| 2024incomplete | 10,186 | $508K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 72% | 72,587 | 23,320 | $5.06M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 19% | 27,144 | 9,586 | $1.34M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.7% | 18,999 | 6,767 | $258K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 1.6% | 5,404 | 1,923 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,650 | 7,503 | $43K |
| 80053 | Comprehensive metabolic panel | <1% | 6,231 | 5,008 | $36K |
| 99001 | <1% | 572 | 442 | $35K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 377 | 220 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,815 | 1,717 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,087 | 2,312 | $12K |
| 80061 | Lipid panel | <1% | 1,693 | 1,640 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 690 | 662 | $10K |
43 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,901 | $10K |
| 80164 | <1% | 703 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 560 | $2K |
| 81001 | <1% | 1,201 | $2K | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 3,086 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $1K |
| 83735 | <1% | 363 | $1K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 4,118 | $1K |
| 84134 | <1% | 124 | $909.59 | |
| 82607 | <1% | 183 | $784.34 | |
| 86141 | <1% | 99 | $645.35 | |
| 82040 | <1% | 456 | $613.73 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,310 | $592.88 |
| 84439 | <1% | 192 | $555.41 | |
| 82746 | <1% | 103 | $554.84 | |
| 82247 | <1% | 415 | $524.21 | |
| 84450 | <1% | 416 | $517.21 | |
| 84460 | <1% | 415 | $511.41 | |
| 84075 | <1% | 415 | $508.80 | |
| 80202 | <1% | 66 | $493.36 | |
| 80177 | <1% | 40 | $371.70 | |
| 84155 | <1% | 416 | $362.40 | |
| 83550 | <1% | 108 | $309.52 | |
| 83540 | <1% | 126 | $301.79 | |
| 85610 | <1% | 161 | $276.07 | |
| 87186 | <1% | 46 | $209.65 | |
| 84100 | <1% | 96 | $163.75 | |
| 84436 | <1% | 70 | $149.12 | |
| 85027 | <1% | 44 | $146.81 | |
| 82248 | <1% | 73 | $140.22 | |
| 80185 | <1% | 18 | $122.55 | |
| 86803 | <1% | 16 | $120.81 | |
| 82140 | <1% | 15 | $113.44 | |
| 87088 | <1% | 43 | $104.37 | |
| 87481 | <1% | 13 | $99.97 | |
| 82274 | <1% | 16 | $85.88 | |
| 82728 | <1% | 39 | $82.60 | |
| 86705 | <1% | 14 | $81.73 | |
| 80076 | <1% | 17 | $81.64 | |
| 87324 | <1% | 14 | $51.74 | |
| 85652 | <1% | 44 | $50.46 | |
| 87449 | <1% | 14 | $49.40 | |
| 85651 | <1% | 17 | $22.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIMMONS, PETER (AUTHORIZED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Pmdlab, LLC | Sacramento, CA | $1.25M |
| Akeso Medical Solutions LLC | San Juan Capistrano, CA | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.